Clinical Trials Browser

Interventional × Retinoblastoma × 90 days × Clear all

NCT05199584 2026-03-05

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

CNSDermatologicEndocrineHead & NeckOther solid neoplasmSarcomaThoracic

Uveal Melanoma, Glioma, Adenoma, Islet Cell, Laryngeal Diseases, Medulloblastoma, Melanoma, Mesothelioma, Neuroblastoma, Pituitary Diseases, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma

NCT02870907 2026-01-07

RB SFCE 09

Phase 2 Active not recruiting

195 enrolled

Other solid neoplasm

Retinoblastoma

NCT05650749 2025-12-29

GPC2

Phase 1 Recruiting

45 enrolled

CNSOther solid neoplasm

Neuroblastoma, Retinoblastoma